fig3

The impact of rituximab prophylaxis on hepatocellular carcinoma recurrence after living donor liver transplantation

Figure 3. Overall survival (A) and recurrence (B) rates after LT in patients with HCC. HCC: Hepatocellular carcinoma; LT: liver transplantation.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/